Streamlining clinical trials, harmonising regulations and improving access to capital should be driving biotech efforts, ...

Dr. Frank Bedu-Addo has served as President, CEO and a director of PDS Biotechnology Corporation since its inception in 2005. Dr. Bedu-Addo is a veteran biotech executive with experience successfully ...

Debut Biotech, a company innovating new molecules, is partnering with Image Skincare to launch a new beauty product, CNBC has learned. The San Diego-based company uses biotechnology and artificial ...

Every year, thousands of biotech breakthroughs stall. Not because the science failed, but because the story did. A survey of biotech investors found that 86% believe that fewer than half of management ...

Biotechnology stocks are wrapping up 2025 on a high note, bouncing back from a rocky start to deliver some of the year’s most impressive gains. What began as a sector weighed down by tariff fears and ...

Jan 8 (Reuters) - Merck (MRK.N), opens new tab is in talks to buy cancer drug developer Revolution Medicines (RVMD.O), opens new tab in a $28 billion to $32 billion deal, the Financial Times reported ...